Filing Flows

Filing Flows › Phibro Animal Health (PAHC) › Q2 FY26

Phibro Animal Health (PAHC) Q2 FY26 earnings results (second quarter fiscal 2026)

10-Q filed Feb 4, 2026

Phibro Animal Health (PAHC) reported revenue of $374M for the second quarter fiscal 2026 (Q2 FY26), +21% from a year earlier and +3% from the quarter before. Operating margin was 13.5%, net earnings $27.5M (7.3% of revenue).

Revenue$374M
Year over year+21%
Quarter over quarter+3%
Operating margin13.5%
Net earnings$27.5M

Phibro Animal Health, Q2 FY26: revenue $374M (+21% year over year), operating margin 13.5%, net earnings $27.5M, operating cash flow $19.4M. The chart follows the revenue to costs, profit and cash.

Q2 FY26AmountQ/QY/Y
Revenue$374M+3%+21%
Gross profit$133M+11%+30%
Operating profit$50.3M-2%+97%
Net earnings$27.5M+4%+762%
Operating cash flow$19.4M+108%+529%
Free cash flow$8.3M——

What changed

Revenue was $373.9M in Q2 FY26, up 21% year over year and up 3% from the previous quarter. MFAs and other was the largest line at 54% of revenue. MFAs and other added $51.8M year over year (up 34%), 80% of the total change. Performance Products declined 10%.

Gross margin was 35.5%, up 2.5 points from a year earlier. Operating profit was $50.3M, a 13.5% margin (up 5.2 points year over year). Of the extra revenue versus a year earlier, 38% reached operating profit, above the 8% margin then. Operating expenses grew 8% against revenue growth of 21%. Net earnings were $27.5M, up 762% year over year. The effective tax rate was 24.6%.

Operating cash flow was $19.4M (up 529% year over year), 70% of net earnings. Non-cash charges added back $12.9M of depreciation and amortization and $434K of share-based compensation. Working capital and other items used $21.4M. Capital expenditures of $11.1M left free cash flow of $8.3M.

Questions

What was Phibro Animal Health's revenue in the second quarter fiscal 2026?

Phibro Animal Health (PAHC) reported revenue of $374M for the second quarter fiscal 2026 (Q2 FY26), +21% from a year earlier and +3% from the quarter before.

Was Phibro Animal Health profitable in the second quarter fiscal 2026?

Operating profit was $50.3M (13.5% of revenue) and net earnings $27.5M.

Open the interactive Sankey →

Source: Phibro Animal Health 10-Q on SEC EDGAR.